Literature DB >> 25745855

Overestimation of free light chain antigen excess rate.

Martine J Vercammen1, Linda Broodtaerts2, Patricia Meirlaen2, Xavier Bossuyt3.   

Abstract

BACKGROUND: Free light chains (FLC) are useful biomarkers for diagnosis and follow-up of plasma cell disorders. FLC quantification is encumbered by non-linearity and antigen excess (>4-fold difference between results obtained at the 2000- and 100-fold dilution).
METHODS: FLC concentration was measured with Freelite® reagents on the BNII, using 100- and 2000-fold dilutions in 3645 samples. Samples displaying antigen excess were re-measured at the 2000- and/or 400-fold dilution. Carryover was evaluated by tracing samples to cuvettes and by measuring a normal sample in cuvettes that previously contained samples with a high FLC concentration.
RESULTS: Antigen excess occurred in 0.93% of samples for κ and in 0.55% of samples for λ. In 81.5% of the cases, it could not be confirmed by a re-analysis of a 2000-fold and/or a 400-fold diluted sample. Real antigen excess was documented in 0.25% and 0.03% of the samples for κ and λ FLC, respectively. In the low concentration range (2000-fold dilution), imprecision was high. False antigen excess was reduced by batch analysis, introducing cleaning and rinsing procedures and using the 400-fold dilution. No antigen excess was detected in samples with normal FLC concentrations.
CONCLUSION: Falsely high results occur by imprecision in the low concentration range and/or by carryover in cuvettes.
Copyright © 2015 Elsevier B.V. All rights reserved.

Keywords:  Antigen excess; Free light chain; Hook effect; Immunoglobulin; Monoclonal gammopathy

Mesh:

Substances:

Year:  2015        PMID: 25745855     DOI: 10.1016/j.cca.2015.02.047

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Effect of specimen type on free immunoglobulin light chains analysis on the Roche Diagnostics cobas 8000 analyzer.

Authors:  Louis S Nelson; Bryan Steussy; Cory S Morris; Matthew D Krasowski
Journal:  Springerplus       Date:  2015-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.